Global Perfusion Imaging Market Size Is Expected To Reach To USD 3692.5 Million By 2035 | CAGR of 3.6%

Global Perfusion Imaging Market Size Is Expected To Reach To USD 3692.5 Million By 2035.

According to a research report published by Spherical Insights & Consulting, the Global Perfusion Imaging Market size is anticipated to grow from USD 2503.7 million in 2025 to USD 3692.5 million by 2035, at a CAGR of 3.6% during the forecast period 2026-2035.

Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the Global Perfusion Imaging Market Size, Share, and Analysis, By Modality Type (Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Doppler Echocardiography), By Application (Coronary Artery Disease (CAD), Myocardial Infarction (MI), Cardiomyopathy, Epilepsy, Dementia, Transplant Evaluation, Brain Trauma, Pulmonary Embolism (PE), Osteonecrosis, and Other Applications), By End User Verticals (Hospitals, Ambulatory Surgery Center, Diagnostic Imaging Centers, and Other End Users), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2026 – 2035. ” Get Detailed Report Description Here:https://www.sphericalinsights.com/press-release/perfusion-imaging-market    

Perfusion imaging is a non-invasive diagnostic modality that measures blood passage through tissues to evaluate oxygenation, crucial for assessing organ function. Used widely for early diagnosis, treatment monitoring, and planning in strokes, neurovascular disorders, and cardiovascular diseases, it plays a vital role in personalized care. The market is driven by rising chronic disease prevalence, an aging population, and the integration of artificial intelligence (AI) to improve diagnostic precision. Key strengths include high-resolution imaging from modern CT/MRI techniques that significantly enhance patient outcomes. However, challenges persist, notably high equipment costs, complex, restrictive regulatory approvals, and a shortage of specialized technicians, especially in emerging regions. The market is rapidly expanding, with significant growth in automated analysis tools.

The single photon emission computed tomography (SPECT) segment dominated the market in 2025 and is projected to grow at a substantial CAGR during the forecast period.

Based on the modality type, the perfusion imaging market is divided into single photon emission computed tomography (SPECT), positron emission tomography (PET), magnetic resonance imaging (MRI), computed tomography (CT), and doppler echocardiography. Among these, the single photon emission computed tomography (SPECT) segment dominated the market in 2025 and is projected to grow at a substantial CAGR during the forecast period. The single photon emission computed tomography (SPECT) segment led market growth, driven by its widespread clinical adoption, high diagnostic accuracy, and versatility in cardiac, neurological, and oncological imaging, positioning it as a key contributor to industry expansion.

The coronary artery disease (CAD) segment accounted for the largest share in 2025 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the perfusion imaging market is divided into coronary artery disease (CAD), myocardial infarction (MI), cardiomyopathy, epilepsy, dementia, transplant evaluation, brain trauma, pulmonary embolism (PE), osteonecrosis, and other applications. Among these, the coronary artery disease (CAD) segment accounted for the largest share in 2025 and is anticipated to grow at a significant CAGR during the forecast period. The coronary artery disease (CAD) segment market growth, fueled by rising prevalence, increasing awareness, advanced diagnostic technologies, and demand for early detection and effective management, is a dominant driver in the cardiovascular market.

The hospitals segment accounted for the highest market revenue in 2025 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end user verticals, the perfusion imaging market is divided into hospitals, ambulatory surgery center, diagnostic imaging centers, and other end users. Among these, the hospitals segment accounted for the highest market revenue in 2025 and is anticipated to grow at a significant CAGR during the forecast period. The hospitals segment market growth, driven by expanding healthcare infrastructure, increasing patient inflow, adoption of advanced diagnostic and interventional technologies, and preference for comprehensive, in-house medical services, solidifies hospitals as the primary revenue contributor.

North America is expected to hold the majority share of the global perfusion imaging market during the forecast period.

North America is expected to hold the majority share of the global perfusion imaging market during the forecast period. North America dominates the perfusion imaging market, driven by advanced healthcare infrastructure, high adoption of innovative imaging technologies, increasing prevalence of cardiovascular and neurological disorders, strong research initiatives, and favorable reimbursement policies, positioning the region as the leading contributor to market growth and technological advancement

Asia Pacific is anticipated to grow at the fastest pace in the global perfusion imaging market during the forecast period. Asia Pacific is expected to grow fastest in the global perfusion imaging market, fueled by rising healthcare expenditure, increasing prevalence of cardiovascular and neurological diseases, expanding diagnostic infrastructure, and growing adoption of advanced imaging technologies across emerging economies.

Major vendors in the global perfusion imaging market are Siemens Healthineers AG, GE HealthCare, Canon Medical Systems Corporation, Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., Bracco Imaging S.p.A., Perimed AB, Shimadzu Corporation, Medtronic plc, Toshiba Medical System, Getinge AB, Neusoft Corporation, Terumo Corporation, Apollo Medical Imaging Technology, and Others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development 

• In June 2025, GE HealthCare highlights molecular imaging innovations, including PET/CT, SPECT/CT, and Flyrcado, for advanced cardiology diagnostics. These technologies enable early detection, precise myocardial perfusion assessment, and personalized treatment monitoring, improving cardiovascular care and patient outcomes amid rising global CVD prevalence.
• In January 2025, Siemens Healthineers showcased advanced diagnostic imaging solutions, including MAGNETOM Flow MRI, SOMATOM Pro.Pulse CT, MULTIX Impact E X-ray, and AI-powered ACUSON Maple and Sequoia ultrasound systems, highlighting innovations in precision medicine, patient care, and sustainable, accessible imaging technologies across the healthcare continuum.
• In October 2024, 4DMedical secures $1.9 million from the Australian Government’s CRC-P grant to expand clinical trials for CT: VQ, in collaboration with I-MED and Macquarie University. The project, CT: VQ A Better Pulmonary Perfusion Test, aims to extract both ventilation and perfusion data from CT scans, enhancing lung diagnostics.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the perfusion imaging market based on the below-mentioned segments:

Global Perfusion Imaging Market, By Modality Type

• Single Photon Emission Computed Tomography (SPECT)
• Positron Emission Tomography (PET)
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT)
• Doppler Echocardiography

Global Perfusion Imaging Market, By Application

• Coronary Artery Disease (CAD)
• Myocardial Infarction (MI)
• Cardiomyopathy
• Epilepsy
• Dementia
• Transplant Evaluation
• Brain Trauma
• Pulmonary Embolism (PE)
• Osteonecrosis
• Other Applications

Global Perfusion Imaging Market, By End User Verticals

• Hospitals
• Ambulatory Surgery Center
• Diagnostic Imaging Centers

• Other End Users

Global Perfusion Imaging Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter